Quite honestly, I don’t consider this hype:
seems like a pretty measured comment to me. Please note that if you want to wait for a RCT study on LDN to be funded, conducted, have data analyzed and published, please be prepared to wait at least 5 years.
Here is the link to the newsletter
https://cortene.wordpress.com/2020/01/
I don't think that they would be proceeding if the drug had demonstrated no positive effect.
https://www.cell.com/cell-metabolism/pdfExtended/S1550-4131(18)30573-4
Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in b Cells
Haven’t read either, but wonder if oligomerization results from overexpression.
Thanks. But T cells still come back after Campath treatment. These new T cells are less likely to be “problematic” like the old ones were because the reconstituted T cells are different/better?
https://www.jimmunol.org/content/191/12/5867...
Lemtrada underwent review by EMA, who restricted use—final approval by EC pending.
https://www.ema.europa.eu/en/medicines/human/referrals/lemtrada
https://medshadow.org/ms-drug-restricted-in-europe/
https://pharmaphorum.com/news/european-regulator-restricts-use-of-sanofi-ms-drug-lemtrada/...
@Jonathan Edwards
Campath-1H is less dangerous in your opinion than cyclophosphamide? Also what is the difference between Campath-1H (humanized) and Alemtuzumab?
Thanks
I would assume the difficulty is in getting MECFS brain cells, not just brain cells per se.
Maybe they could induce MECFS in the cells with Cipro or the anti-cancer compounds that @RDP mentioned in other threads
https://www.medpagetoday.org/rheumatology/arthritis/83966?_ga=2.265148431.1072804894.1576686559-674435307.1570713348
Journal article here
https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-019-2059-8
Looks like vitality and insomnia improved on this.
Yeah brain cells too. But they would need to get cells from MECFS patients.
First cell culture of live adult human neurons shows potential of brain cell types
https://www.sciencedaily.com/releases/2017/01/170117141149.htm
@Badpack
Is it possible that the plasmapheresis did not remove the “bad stuff” (exosomes) because they were not the right size? I assume that plasma filters are designed to remove specific size antibodies and maybe the “something in the plasma” was too small to be removed by the filters?
https://www.nytimes.com/2019/12/07/us/dna-bone-marrow-transplant-crime-lab.html
Interesting... wonder if pwmecfs could benefit from a bone marrow transplant, especially since all of the blood will have the donor’s genotype. In other words, maybe the blood after transplant won’t have...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.